Drug Enforcement Administration January 2014 – Federal Register Recent Federal Regulation Documents

Ralph J. Chambers, M.D.; Decision and Order
Document Number: 2014-01797
Type: Notice
Date: 2014-01-30
Agency: Drug Enforcement Administration, Department of Justice
House of Medicine; Decision and Order
Document Number: 2014-01794
Type: Notice
Date: 2014-01-30
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; Clinical Supplies Management, Inc.
Document Number: 2014-01788
Type: Notice
Date: 2014-01-30
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Halo Pharmaceutical, Inc.
Document Number: 2014-01785
Type: Notice
Date: 2014-01-30
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; United States Pharmacopeial Convention
Document Number: 2014-01784
Type: Notice
Date: 2014-01-30
Agency: Drug Enforcement Administration, Department of Justice
Controlled Substances: 2014 Proposed Aggregate Production Quota for Three Temporarily Controlled Synthetic Phenethylamines
Document Number: 2014-01778
Type: Notice
Date: 2014-01-30
Agency: Drug Enforcement Administration, Department of Justice
Three synthetic phenethylamines 2-(4-iodo-2,5- dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5), 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82), and 2- (4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36) were temporarily placed in schedule I of the Controlled Substances Act (CSA) by a final order published by the Drug Enforcement Administration (DEA) on November 15, 2013 (78 FR 68716). This means that any manufacturer that wishes to manufacture 25I-NBOMe, 25C-NBOMe, or 25B-NBOMe after November 15, 2013, must be registered with the DEA and have obtained a manufacturing quota for 25I-NBOMe, 25C-NBOMe, or 25B-NBOMe pursuant to 21 CFR part 1303. The DEA cannot issue individual manufacturing quotas for 25I-NBOMe, 25C-NBOMe, or 25B- NBOMe unless and until it establishes an aggregate production quota. Therefore, this notice proposes a 2014 aggregate production quota for 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe.
Importer of Controlled Substances; Notice of Registration; Cambrex Charles City, Inc.
Document Number: 2014-01707
Type: Notice
Date: 2014-01-30
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Irix Manufacturing, Inc.
Document Number: 2014-01781
Type: Notice
Date: 2014-01-29
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Temporary Placement of 10 Synthetic Cathinones into Schedule I
Document Number: 2014-01172
Type: Proposed Rule
Date: 2014-01-28
Agency: Drug Enforcement Administration, Department of Justice
The Deputy Administrator of the Drug Enforcement Administration (DEA) is issuing this notice of intent to temporarily schedule 10 synthetic cathinones into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act (CSA). The 10 substances are: (1) 4-methyl-N-ethylcathinone (``4-MEC''); (2) 4-methyl-alpha-pyrrolidinopropiophenone (``4-MePPP''); (3) alpha- pyrrolidinopentiophenone (``[alpha]-PVP''); (4) 1-(1,3-benzodioxol-5- yl)-2-(methylamino)butan-1-one (``butylone''); (5) 2-(methylamino)-1- phenylpentan-1-one (``pentedrone''); (6) 1-(1,3-benzodioxol-5-yl)-2- (methylamino)pentan-1-one (``pentylone''); (7) 4-fluoro-N- methylcathinone (``4-FMC''); (8) 3-fluoro-N-methylcathinone (``3- FMC''); (9) 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (``naphyrone''); and (10) alpha-pyrrolidinobutiophenone (``[alpha]- PBP''). This action is based on a finding by the Deputy Administrator that the placement of these synthetic cathinones into schedule I of the CSA is necessary to avoid an imminent hazard to the public safety. Any final order will be published in the Federal Register and may not be effective prior to February 27, 2014. Any final order will impose the administrative, civil, and criminal sanctions and regulatory controls applicable to schedule I substances under the CSA on the manufacture, distribution, possession, importation, exportation, research, and conduct of instructional activities of these synthetic cathinones.
Roderick Lee Mitchell, M.D.; Decision and Order
Document Number: 2014-01159
Type: Notice
Date: 2014-01-22
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Application: Noramco, Inc.
Document Number: 2014-01158
Type: Notice
Date: 2014-01-22
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Noramco, Inc.
Document Number: 2014-01157
Type: Notice
Date: 2014-01-22
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; Noramco, Inc.
Document Number: 2014-01156
Type: Notice
Date: 2014-01-22
Agency: Drug Enforcement Administration, Department of Justice
James Clopton, M.D.; Decision and Order
Document Number: 2014-00524
Type: Notice
Date: 2014-01-14
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Temporary Placement of Four Synthetic Cannabinoids Into Schedule I
Document Number: 2014-00217
Type: Proposed Rule
Date: 2014-01-10
Agency: Drug Enforcement Administration, Department of Justice
The Deputy Administrator of the Drug Enforcement Administration (DEA) is issuing this notice of intent to temporarily schedule four synthetic cannabinoids into Schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act (CSA). The substances are: quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB- 22; QUPIC); quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22); N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4- fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA); and N-(1-amino- 3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxam ide (ADB- PINACA). This action is based on a finding by the Deputy Administrator that the placement of these synthetic cannabinoids into Schedule I of the CSA is necessary to avoid an imminent hazard to the public safety. Any final order will impose the administrative, civil, and criminal sanctions and regulatory controls applicable to Schedule I substances under the CSA on the manufacture, distribution, possession, importation, exportation, research, and conduct of instructional activities of these synthetic cannabinoids.
Importer of Controlled Substances; Notice of Registration; Mylan Pharmaceuticals, Inc.
Document Number: 2014-00206
Type: Notice
Date: 2014-01-10
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances Notice of Application Cody Laboratories, Inc.
Document Number: 2014-00204
Type: Notice
Date: 2014-01-10
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Cody Laboratories, Inc.
Document Number: 2014-00203
Type: Notice
Date: 2014-01-10
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances, Notice of Application, Myoderm
Document Number: 2014-00202
Type: Notice
Date: 2014-01-10
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Siegfried USA, LLC.
Document Number: 2014-00201
Type: Notice
Date: 2014-01-10
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Cayman Chemical Company
Document Number: 2014-00200
Type: Notice
Date: 2014-01-10
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Organix, Inc.
Document Number: 2014-00198
Type: Notice
Date: 2014-01-10
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Fresenius Kabi USA, LLC.
Document Number: 2014-00197
Type: Notice
Date: 2014-01-10
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; Fisher Clinical Services, Inc.
Document Number: 2014-00179
Type: Notice
Date: 2014-01-10
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; Cerilliant Corporation
Document Number: 2014-00057
Type: Notice
Date: 2014-01-08
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Noramco, Inc. (GA)
Document Number: 2014-00054
Type: Notice
Date: 2014-01-08
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Siegfried (USA), LLC
Document Number: 2014-00053
Type: Notice
Date: 2014-01-08
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Hospira
Document Number: 2013-31364
Type: Notice
Date: 2014-01-02
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; American Radiolabeled Chemicals, Inc.
Document Number: 2013-31363
Type: Notice
Date: 2014-01-02
Agency: Drug Enforcement Administration, Department of Justice